# dihydroartemisinin/piperaquine = dha/ppq

### notes
+ prescription under medical supervision

### therapeutic action
+ antimalarial

### indications
+ treatment of uncomplicated falciparum malaria
+ completion treatment follow colecalciferoling parenteral therapy for severe falciparum malaria

### presentation
+ co-formulated tablets of dihydroartemisinin (dha)/piperaquine (ppq), in blister pack, for a complete treatment for one individual
+ there are 5 different blister packs:
    - 20 mg dha/160 mg ppq tablets blister pack of 3 tablets
    - 40 mg dha/320 mg ppq tablets blister pack of 3 tablets
    - 40 mg dha/320 mg ppq tablets blister pack of 6 tablets
    - 40 mg dha/320 mg ppq tablets blister pack of 9 tablets
    - 40 mg dha/320 mg ppq tablets blister pack of 12 tablets

### dosage and duration
+ child 5 to 25 kg: 2.5 to 10 mg/kg/day of dha + 20 to 32 mg/kg/day of ppq
+ child over 25 kg and adult: 2 to 10 mg/kg/day of dha + 16 to 27 mg/kg/day of ppq
20 mg/160 mg
tablet

40 mg/320 mg
tablet

8 to < 11 kg

1½ tab

-

17 to < 25 kg

-

weight

5 to < 8 kg

11 to < 17 kg

1 tab
-

weight

20 mg/160 mg
tablet

40 mg/320 mg
tablet

36 to < 60 kg

-

3 tab

-

25 to < 36 kg

1 tab

60 to < 80 kg

1½ tab

+ tablets are to be taken once daily for 3 days.

≥ 80 kg



-
-
-

2 tab
4 tab
5 tab

### contra-indications, adverse effects, precautions
+ do not administer in the event of cardiac disorders (bradycardia, heart rhythm disorders, congestive heart failure).
+ do not combine with drugs that prolong the qt interval (amiodarone, erythromycin, haloperidol, pentamidine, fluconazole, etc.).
+ administer with caution to patients > 60 years or with renal or hepatic impairment.
+ may cause: cardiac disorders (qt prolongation, tachycardia); rarely, gastrointestinal disturbances, pruritus, hepatic disorders, joint and muscle pain.
+ monitor combination with: antiretrovirals (increased blood levels of these drugs), enzymes inducers such as rifampicin, carbamazepine, phenytoin, phenobarbital (reduced blood levels of dha/ppq).
+ if the patient vomits within 30 minutes after administration, re-administer the full dose; if the patient vomits within 30 to 60 minutes, re-administer half the dose.
+ *pregnancy*: no contra-indication
+ *breast-feeding*: no contraindication

### remarks
+ take between meals, with a glass of water.
+ the tablets may be crushed and mixed with water.
+ storage: below 25°c